Last reviewed · How we verify
ECP-1014
At a glance
| Generic name | ECP-1014 |
|---|---|
| Also known as | GIBH-1014 |
| Sponsor | Euclises Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ECP-1014 CI brief — competitive landscape report
- ECP-1014 updates RSS · CI watch RSS
- Euclises Pharmaceuticals, Inc. portfolio CI